[Clinical path for mFOLFOX6 describing criteria for reduction and suspension of drugs].
Okada N, Ishibashi K, Ohsawa T, Sobajima J, Kuwabara K, Ishiguro T, Amano K, Hatano S, Hokama N, Tajima Y, Ishii M, Yokoyama Y, Yamamoto A, Kumamoto K, Haga N, Ishida H.
Okada N, et al. Among authors: hatano s.
Gan To Kagaku Ryoho. 2010 Nov;37(12):2588-90.
Gan To Kagaku Ryoho. 2010.
PMID: 21224648
Japanese.